MedPath

The Effects of Ethyl-Alpha-Guanido-Methyl Ethanoate on Skin Reactions From Glatiramer Acetate Injections

Phase 4
Withdrawn
Conditions
Multiple Sclerosis
Interventions
Drug: 1% Steroid Cream
Drug: topical placebo cream with no active ingredients
Drug: AGEE cream
Registration Number
NCT00988988
Lead Sponsor
University of Nebraska
Brief Summary

Participants with multiple sclerosis that are currently treated with glatiramer acetate (GA, Copaxone®) injections and have redness, pain, swelling, itching or a lump at the injection site will be recruited to examine histamine response of three topical treatments to reduce these symptoms.

Detailed Description

Participants are asked to be in this study because they have multiple sclerosis, are currently treated with glatiramer acetate (GA, Copaxone®) injections and have redness, pain, swelling, itching or a lump at the injection site.

The purpose of this study is to determine if the use of ethyl-a-guanida-methyl ethanoate (AGEE) will decrease histamine response measured by redness, swelling, and itch response following subcutaneous injection of glatiramer acetate (GA) for the treatment of Multiple Sclerosis (MS).

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Able to give informed consent
  • Between ages 19-65
  • Laboratory supported diagnosis of multiple sclerosis
  • Currently treated with injectable GA, experiencing wheal and flare after injection
Exclusion Criteria
  • Unable to give informed consent
  • Treated with any other therapy for Multiple Sclerosis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Steroid Cream1% Steroid Cream1% steroid cream
placebotopical placebo cream with no active ingredientsinactive cream
AGEE creamAGEE creamAGEE cream is a creatine ethyl ester based product (an amino acid) that can be purchased over-the-counter without a prescription and is not FDA controlled
Primary Outcome Measures
NameTimeMethod
Histamine response after ethyl-α-guanida-methyl ethanoate (AGEE) and subcutaneous injection of glatiramer acetateThree weeks

To determine if the use of ethyl-α-guanida-methyl ethanoate (AGEE) will decrease histamine response measured by wheal, flare and itch response following subcutaneous injection of glatiramer acetate for the treatment of Multiple Sclerosis

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath